| Preview | Issue Date | Title / Name | Author(s) |
| 2018 | Application of an incident taxonomy for radiation therapy: Analysis of five years of data from three integrated cancer centres. | Greenham, S.; Manley, S.; Turnbull, K.; Hoffmann, M.; Fonseca, A.; Westhuyzen, J.; Last, A.; Aherne, N.; Shakespeare, T.; Greenham, Stuart; Hoffmann, Matthew; Turnbull, Kirsty; Westhuyzen, Justin; Last, Andrew; Aherne, Noel; Shakespeare, Thomas P. | |
| Sep-2021 | Assessing ISUP prostate cancer grade groups in patients treated with definitive dose escalated external beam radiation | Toby, J.; Eade, T.; Hruby, G.; Kneebone, A.; Aherne, N.; Brown, C.; Guo, L.; Hoffmann, M.; Shaekspeare, T. P.; Aherne, Noel; Hoffmann, Matthew; Shakespeare, Thomas P. | |
| Feb-2021 | Assessment of genetic referrals and outcomes for women with triple negative breast cancer in regional cancer centres in Australia. | Hallenstein, L.; Sorensen, C.; Hodgson, L.; Wen, S.; Westhuyzen, J.; Hansen, C.; Last, A.; Amalaseelan, J.V.; Salindera, S.; Ross, W.; Spigelman, A.D.; Shakespeare, T.; Aherne, N.; Hallenstein, L.; Sorensen, C.; Wen, S.; Westhuyzen, Justin; Hansen, Carmen; Last, Andrew; Shakespeare, Thomas P.; Aherne, Noel | |
| 2020 | Bone health assessment by dual X-ray absorptiometry (DXA) scan in men commencing adjuvant androgen deprivation therapy (ADT) for prostate cancer. | Pan, B.; Aherne, N.; Shakespeare, T.; Grossmann, M.; Wong, P.; Pan, Belinda; Aherne, Noel; Shakespeare, Thomas P. | |
| Jan-2017 | Hippocampal avoidance prophylactic cranial irradiation in small cell lung carcinoma | Aherne, N.; Tune, D.; Ross, A.; Dwyer, P.; Last, A.; Aherne, Noel; Tune, Deanna; Ross, A.; Last, Andrew | |
| Aug-2021 | Implementation of the Australian Computer-Assisted Theragnostics (AusCAT) network for radiation oncology data extraction, reporting and distributed learning | Field, M.; Vinod, S.; Aherne, N.; Carolan, M.; Dekker, A.; Delaney, G.; Greenham, S.; Hau, E.; Lehmann, J.; Ludbrook, J.; Miller, A.; Rezo, A.; Selvaraj, J.; Sykes, J.; Holloway, L.; Thwaites, D.; Aherne, Noel; Greenham, Stuart | |
| Jan-2014 | Improved outcomes with intensity modulated radiation therapy combined with temozolomide for newly diagnosed glioblastoma multiforme | Aherne, N.; Benjamin, L. C.; Horsely, P. J.; Silva, T.; Wilcox, S.; Amalaseelan, J.; Dwyer, P.; Tahir, A. R. M.; Hill, J.; Last, A.; Hansen, C.; McLachlan, C. S.; Lee, Y. L.; McKay, M. J.; Shakespeare, T. P.; Aherne, Noel; Benjamin, Linus C.; Horsley, Patrick J.; Wilcox, Shea; Tahir, Abdul R. M.; Hill, Jacques; Hansen, Carmen; Shakespeare, Thomas P. | |
| Mar-2019 | An investigation of the incidence and severity of patient related side effects following radiation therapy treatment of the head and neck | Winkley, L.; Surjan, Y.; Aherne, N.; Warren-Forward, H.; Aherne, Noel | |
| Oct-2016 | Long-Term Decision Regret After Postprostatectomy Image Guided Intensity Modulated Radiation Therapy | Shakespeare, T. P.; Chin, S.; Hoffmann, M.; Aherne, N.; Shakespeare, Thomas P.; Hoffmann, Matthew; Aherne, Noel | |
| Jun-2020 | Long‐term outcomes of patients with conserved breast cancer treated with adjuvant hypo fractionated prone breast intensity‐modulated radiation therapy | Gortman, A.M.; Amalaseelan, J.; Shakespeare, T.; Aherne, N.; Westhuyzen, J.; Chamberlain, L.; Last, A.; Shakespeare, Thomas P.; Aherne, Noel; Westhuyzen, Justin; Chamberlain, L.; Last, Andrew | |
| Jul-2021 | Machine learning applications in radiation oncology | Field, M.; Hardcastle, N.; Jameson, M.; Aherne, N.; Hollway, L.; Aherne, Noel | |
| Jul-2021 | Metaplastic carcinoma of the breast: Clinicopathological features and treatment outcomes with long-term follow up. | Gortman, A.; Aherne, N.; Westhuyzen, J.; Amalaseelan, J.V.; Dwyer, P.M.; Hoffmann, M.; Last, A.; Shakespeare, T.; Gortman, A.; Aherne, Noel; Westhuyzen, Justin; Hoffmann, Matthew; Last, Andrew; Shakespeare, Thomas P. | |
| Dec-2019 | PSMA-PET guided dose-escalated volumetric arc therapy (VMAT) for newly diagnosed lymph node positive prostate cancer: Efficacy and toxicity outcomes at two years | Shakespeare, T. P.; Eggert, E.; Wood, M.; Westhuyzen, J.; Turnbull, K.; Rutherford, N.; Aherne, N.; Shakespeare, Thomas P.; Eggert, Elizabeth; Wood, Maree; Westhuyzen, Justin; Turnbull, Kirsty; Aherne, Noel | |
| Jun-2023 | PSMA-PET-guided dose-escalated volumetric arc therapy for newly diagnosed lymph node-positive prostate cancer: 5 Year outcomes following the FROGG and EviQ node-positive guidelines | Yap, S. Z. L; Armstrong, S.; Aherne, N.; Shakespeare, T. P.; Yap, Shaun Z.; Aherne, Noel; Shakespeare, Thomas P. | |
| Dec-2023 | SABR for Early Non-Small Cell Lung Cancer: Changes in Pulmonary Function, Dyspnea, and Quality of Life | Ahn, J.; Yeghiaian-Alvandi, R.; Hegi-Johnson, F.; Browne, L. H.; Graham, P. H.; Chin, Y.; Gee, H.; Vinad, S.; Ludbrook, J.; Last, A; Dwyer, P.; Ong, A.; Aherne, N.; Azzi, M.; Hau, E.; Last, Andrew; Aherne, Noel | |
| Oct-2019 | Validation of the prognostic ability of the five-tiered ISUP grade groups for prostate cancer treated with definitive dose-escalated external beam radiation treatment in a contemporary Australian population | Toby, J.; Shakespeare, T. P.; Aherne, N.; Brown, C.; Guo, L.; Hoffman, M.; Hruby, G.; Kneebone, A.; Eade, T.; Shakespeare, Thomas P.; Aherne, Noel; Hoffmann, Matthew | |
